CIBA VISION's mission is "Better Eyes for a Better Life." To achieve this goal we are constantly examining new materials, therapeutic agents and delivery systems to yield the next eye care breakthroughs.
Our researchers are backed by significant global Research and Development (R&D) resources from both CIBA VISION and Novartis. In 2005, we invested approximately USD 4.8 billion in R&D. Together, we explore and develop innovative approaches to address a variety of vision care needs, eye diseases and conditions.
O2OPTIX™ - Breathable contact lenses with up to 5 times more oxygen transmissibility than traditional daily wear soft contact lenses.
Focus® DAILIES® – one-day disposable lenses, preferred three-to-one over other daily disposable lenses among patients participating in multinational clinical trials
NIGHT & DAY® – the first contact silicone hydrogel contact lenses for continuous wear for up to 30 nights and days
FreshLook® ColorBlends® - the first lens with 3-in-1 technology, blending three colors into one to create the subtle, natural depth of beautiful eyes.
Focus® Progressives – innovative lenses for presbyopic correction delivering excellent near vision without compromising intermediate and distance acuity
Focus® Toric Monthly Lenses – the first monthly replacement toric soft contact lens on the market for astigmatism
FreshLook Radiance™ –the first cosmetic contact lenses available
that add beautiful pearlescent effects to both light and dark eyes to
give sparkle and shine to your natural eye color
AQuify® Comfort Drops – the first lens drops with sodium hyaluronate to help provide long-lasting comfort.
AQuify® Multi-Purpose Solution (MPS) – the first 5-minute multi-purpose
solution cleared for use with silicone hydrogel lenses.